Double-Dose flu shot trial aims to protect vulnerable transplant patients
NCT ID NCT05215327
Summary
This study is testing whether a higher-dose flu vaccine given twice in one season is more effective than the standard dose for people who have received a lung transplant. Lung transplant recipients are at high risk for severe flu because their anti-rejection medications weaken their immune systems. Researchers will compare the immune response and safety of the two vaccine strategies in about 270 participants who are 1 to 35 months post-transplant.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFLUENZA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Vanderbilt University Medical Center
RECRUITINGNashville, Tennessee, 37232, United States
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.